Henry Schein Inc (NAS:HSIC)
$ 73.31 -0.13 (-0.18%) Market Cap: 9.39 Bil Enterprise Value: 11.95 Bil PE Ratio: 24.68 PB Ratio: 2.62 GF Score: 88/100

Henry Schein Inc at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 02:45PM GMT
Release Date Price: $60.15 (+0.74%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

Okay, great. We're going to start our next session here. I'm Steve Valiquette, the health care services analyst here at Barclays. Our next session here in day 2 of the conference is with Henry Schein. We have the company's CFO, Steve Paladino. This will be a fireside chat, so there's plenty of things to talk about in the world of dental and medical and I'm sure we'll touch a little bit maybe on the vet side, too, just given the recent spinoff, as well. So, Steve, welcome.

Steven Paladino
Henry Schein, Inc. - Executive VP, CFO & Executive Director

Thank you, Steven.

Questions & Answers

Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. Great, so maybe let's just talk about dental first since I think a lot of investors still think of the company as that being the primary driver of the investment thesis. From time to time, there seems to be some pockets of deceleration in dental. It's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot